These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 19887554)
1. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554 [TBL] [Abstract][Full Text] [Related]
2. Involvement of the CB Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors. Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297 [TBL] [Abstract][Full Text] [Related]
5. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft. Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457 [TBL] [Abstract][Full Text] [Related]
6. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro. Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619 [TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs. Ruhl T; Karthaus N; Kim BS; Beier JP Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Sarfaraz S; Afaq F; Adhami VM; Mukhtar H Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356 [TBL] [Abstract][Full Text] [Related]
9. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria. Maggo S; Ashton JC J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development. Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in the treatment of cancer. Alexander A; Smith PF; Rosengren RJ Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435 [TBL] [Abstract][Full Text] [Related]
12. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner. Roberto D; Klotz LH; Venkateswaran V Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861 [TBL] [Abstract][Full Text] [Related]
16. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830 [TBL] [Abstract][Full Text] [Related]
17. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. Ikeda H; Ikegami M; Kai M; Ohsawa M; Kamei J Neuroscience; 2013 Oct; 250():446-54. PubMed ID: 23892011 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors. Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202 [TBL] [Abstract][Full Text] [Related]
20. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Rahn EJ; Makriyannis A; Hohmann AG Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]